Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

[1]  O. Ståhl,et al.  Surveillance vs. adjuvant therapy of clinical stage I testicular tumors – a review and the SWENOTECA experience , 2015, Andrology.

[2]  L. Bachrach,et al.  Patterns of performance of retroperitoneal lymph node dissections by American urologists: most retroperitoneal lymph node dissections in the United States are performed by low-volume surgeons. , 2014, Urology.

[3]  S. Daneshmand,et al.  United States trends in patterns of care in clinical stage I testicular cancer: Results from the National Cancer Database (1998-2011). , 2014 .

[4]  A. Stewart,et al.  Monitoring the delivery of cancer care: Commission on Cancer and National Cancer Data Base. , 2012, Surgical oncology clinics of North America.

[5]  L. Collette,et al.  Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working Party. , 1999, Journal of the National Cancer Institute.

[6]  E. Feuer,et al.  Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer. , 1999, Journal of the National Cancer Institute.

[7]  E. Feuer,et al.  After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  S. Kaye,et al.  Management of malignant teratoma: does referral to a specialist unit matter? , 1993, The Lancet.

[9]  L. Baldetorp,et al.  Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  L. Einhorn Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. , 1981, Cancer research.